Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery.

Pharmacogenomics
Wei Zhang, M Eileen Dolan

Abstract

The 1000 Genomes Project aims to provide detailed genetic variation data on over 1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International HapMap samples that are composed of lymphoblastoid cell lines derived from individuals of different world populations. These same samples have been used in pharmacogenomic discovery and validation. For example, a cell-based, genome-wide approach using the HapMap samples has been used to identify pharmacogenomic loci associated with chemotherapeutic-induced cytotoxicity with the goal to identify genetic markers for clinical evaluation. Although the coverage of the current HapMap data is generally high, the detailed map of human genetic variation promised by the 1000 Genomes Project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource may greatly enhance our understanding of the genetic basis of drug response and other complex traits (e.g., gene expression), therefore, help advance personalized medicine.

References

Oct 16, 1999·Science·A P Wolffe, M A Matzke
Mar 22, 2001·Pharmacogenomics·R Judson, J C Stephens
Nov 10, 2001·Annual Review of Genomics and Human Genetics·W E Evans, J A Johnson
Jun 5, 2002·Genome Research·W James KentDavid Haussler
Jul 12, 2002·Nature·Paul Van EerdeweghTim P Keith
Feb 5, 2003·Nature Genetics·Vivian G CheungRichard S Spielman
Apr 4, 2003·Nature·Michael Cherry
Jun 20, 2003·Nature·Charlotte Westney
Aug 2, 2003·Investigational New Drugs·Etienne ChatelutPierre Canal
Dec 20, 2003·Nature·UNKNOWN International HapMap Consortium
May 22, 2004·Nature Reviews. Genetics·UNKNOWN International HapMap Consortium
Jul 30, 2004·Proceedings of the National Academy of Sciences of the United States of America·James W WattersHoward L McLeod
Aug 3, 2004·Nature Genetics·A John IafrateCharles Lee
Oct 23, 2004·Science·UNKNOWN ENCODE Project Consortium
Oct 7, 2005·Pharmacogenomics·Frank J Steemers, Kevin L Gunderson
Oct 29, 2005·Nature·UNKNOWN International HapMap Consortium
Dec 16, 2005·Pharmacogenomics·Karim OuahchiCharles Lee
Apr 4, 2006·Annals of Medicine·Elisabeth B Binder, Florian Holsboer
Sep 20, 2006·BMC Genomics·Erwin TantosoKuo-Bin Li
Jan 9, 2007·Nature Genetics·Richard S SpielmanVivian G Cheung
Feb 10, 2007·Science·Barbara E StrangerEmmanouil T Dermitzakis
Jun 1, 2007·Proceedings of the National Academy of Sciences of the United States of America·R Stephanie HuangM Eileen Dolan
Jul 11, 2007·Current Opinion in Lipidology·Lara M Mangravite, Ronald M Krauss
Aug 19, 2007·American Journal of Human Genetics·R Stephanie HuangM Eileen Dolan
Oct 19, 2007·Nature·UNKNOWN International HapMap ConsortiumJohn Stewart
Nov 29, 2007·Journal of Human Genetics·Fumihiko TakeuchiNorihiro Kato
Jan 25, 2008·Nature·Erika Check Hayden
Jan 25, 2008·Nature·Rachel Courtland
Mar 4, 2008·American Journal of Human Genetics·Wei ZhangM Eileen Dolan
Mar 5, 2008·Bioinformation·Wei Zhang, M Eileen Dolan
Mar 22, 2008·Genome Génome / Conseil National De Recherches Canada·Jennifer S HawkinsJonathan F Wendel
Mar 29, 2008·Science·Oliver Hobert
Apr 5, 2008·Science·Timothy D HarrisZheng Xie
Apr 9, 2008·Bioinformatics and Biology Insights·Wei ZhangM Eileen Dolan
May 3, 2008·Cancer Research·R Stephanie HuangM Eileen Dolan
May 10, 2008·Journal of Chemotherapy·P BiasonG Toffoli
Jun 14, 2008·Genome Research·Weichun Huang, Gabor Marth
Jun 26, 2008·Annual Review of Genomics and Human Genetics·Elaine R Mardis
Aug 1, 2008·Current Clinical Pharmacology·Shufeng Zhou
Sep 4, 2008·Molecular Cancer Therapeutics·R Stephanie HuangM Eileen Dolan
Nov 22, 2008·Science·John EidStephen Turner

❮ Previous
Next ❯

Citations

Nov 28, 2012·Nature Reviews. Genetics·Heather E WheelerMark J Ratain
Nov 6, 2010·Nucleic Acids Research·Chie MotonoMotonori Ota
Jun 10, 2010·Nucleic Acids Research·Jingyuan RenWilfred W Li
May 13, 2010·BMC Bioinformatics·Daniel RiosFiona Cunningham
Jan 19, 2011·BMC Bioinformatics·Tiago Antao
May 13, 2010·BMC Genomics·Yuan ChenPaul Flicek
Aug 26, 2011·Globalization and Health·Catherine Olivier, Bryn Williams-Jones
Jun 9, 2012·Pharmacogenomics·Joseph HensonZemin Ning
Dec 2, 2011·Annual Review of Food Science and Technology·J Bruce GermanJennifer T Smilowitz
Apr 4, 2015·International Journal of Cardiology·Payman Shahabi, Marie-Pierre Dubé
Apr 12, 2011·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Jun ZhangGenfa Zhang
Sep 16, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Melanie HandschickBurkhard Tümmler
Nov 27, 2010·American Journal of Human Genetics·Amy L StarkM Eileen Dolan
Feb 8, 2018·Journal of Human Genetics·Mariam Al-AliHabiba S AlSafar
Sep 15, 2018·The Pharmacogenomics Journal·Jihoon ChoiQing Ling Duan
Aug 30, 2011·American Journal of Human Genetics·Aaron G Day-WilliamsEleftheria Zeggini
May 26, 2011·Current Opinion in Pediatrics

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

UCSC Genome Browser
EagleView
PharmGKB
SeqAlign
Ensembl
Transcript SNP View
MapView

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature
International HapMap Consortium
Annual Review of Genomics and Human Genetics
Elaine R Mardis
Nature
E S LanderInternational Human Genome Sequencing Consortium
© 2021 Meta ULC. All rights reserved